Next-Generation Vibro-Acoustography Platform for Personalized Medicine and Real-Time Tissue Analysis

A revolutionary vibro-acoustography platform that integrates hybrid transducers, machine learning-based signal processing, and cloud-based data analytics to enable real-time, label-free, and non-invasive tissue analysis and personalized medicine.

The original patent on multi-frequency harmonic acoustography for target identification and border detection has limitations in terms of resolution, speed, and clinical applicability. The new inventive concept addresses these limitations by introducing a hybrid transducer that combines acoustic and optical sensing, enabling real-time monitoring of tissue properties and personalized treatment plans.

The next-generation vibro-acoustography platform comprises a compact, wearable transducer array that emits and detects acoustic waves, a hybrid transducer incorporating a piezoelectric element and an optical sensor, and a machine learning-based signal processor. The platform can generate high-resolution, multi-frequency images of target tissues and provide real-time feedback on changes in tissue properties. The cloud-based database of tissue properties and machine learning-based algorithm enable personalized treatment plans and real-time monitoring of treatment efficacy.

The new claims introduce a paradigm shift in vibro-acoustography by combining acoustic and optical sensing, enabling real-time monitoring of tissue properties, and integrating machine learning-based signal processing and cloud-based data analytics. These advancements provide a significant improvement over the original patent, enabling personalized medicine and real-time tissue analysis.

Alternative embodiments of the inventive concept could include the use of different types of sensors, such as electromagnetic or thermal sensors, or the integration of other imaging modalities, such as ultrasound or MRI. Variations of the platform could be designed for specific clinical applications, such as cancer diagnosis or cardiovascular disease monitoring.

The next-generation vibro-acoustography platform has significant commercial potential in the fields of personalized medicine, medical imaging, and healthcare analytics. The platform could be marketed to hospitals, research institutions, and pharmaceutical companies, with potential applications in cancer diagnosis, cardiovascular disease monitoring, and neurodegenerative disease research.